Previous Close | 76.29 |
1-Year Change | 174.42% |
6-Months Change | 1.27% |
3-Months Change | 11.67% |
Moving Avg (50d) | 72.315 |
Moving Avg (200d) | 64.389 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 10.9B |
Beta (3-Years) | 1.12 |
Revenue Growth (ttm) | 15.95% |
Net Profit Margin (ttm) | -257.69% |
Return On Assets (ttm) | -54.62% |
EPS (ttm) | -5.29 |
PE Ratio (ttm) | -14.42 |
Dividend Yield | % |
Asset Description: | Insmed Incorporated |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-15 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
74.764 | 72.476 | 70.95 | 68.661 | 64.847 | 61.032 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.